Minapharm, ProBioGen deal

Minapharm acquired 95% of ProBioGen for €30.4 million ($36.8 million), including undisclosed earn-outs. ProBioGen is a contract manufacturer focusing on cell line development and engineering. The companies partnered in 2007 to develop two undisclosed therapeutic proteins for endocrine and coagulation disorders (see BioCentury, April 23, 2007). ...